Phase 1 clinical trial to assess safety and efficacy of NY-ESO-1-specific TCR T cells in HLA-A∗02:01 patients with advanced soft tissue sarcomaQiuzhong Pan, Xing Zhang, Aiyuan Chen et al.|Cell Reports Medicine|2023Cited by 50